Floatz logo

Therapeutic Asset Ratings

245 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Gtx-006
Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP4BB (65)
Bendamustine
Mantle Cell Lymphoma
Tianjin Medical University Cancer Institute and HospitalP3BB (65)
Surufatinib
Pancreas Cancer
Tianjin Medical University Cancer Institute and HospitalP3BB (65)
(+)-VINCRISTINE
Childhood Cancer
Tianjin Medical University Cancer Institute and HospitalP2BB (65)
Eloxatin
Liver Metastasis
Tianjin Medical University Cancer Institute and HospitalP3BB (64)
Famitinib
EGFR Activating Mutation
Tianjin Medical University Cancer Institute and HospitalP3BB (64)
Pyrotinib
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and HospitalP3BB (64)
Pyrotinib
Hormone Receptor Positive Malignant Neoplasm of Breast
Tianjin Medical University Cancer Institute and HospitalP3BB (64)
rc48-adc
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and HospitalP3BB (64)
Cetuximab
Cetuximab
Tianjin Medical University Cancer Institute and HospitalP3B (63)
Irinotecan
Brain Metastases
Tianjin Medical University Cancer Institute and HospitalP3B (63)
Irinotecan
Liver Metastasis
Tianjin Medical University Cancer Institute and HospitalP3B (63)
(+)-VINCRISTINE
Brain Metastases
Tianjin Medical University Cancer Institute and HospitalP3B (63)
Cetuximab
BRAF V600E
Tianjin Medical University Cancer Institute and HospitalP2B (63)
Benadryl
Advanced and Metastatic NSCLC
Tianjin Medical University Cancer Institute and HospitalP3B (62)
HYDROMORPHON
Advanced and Metastatic NSCLC
Tianjin Medical University Cancer Institute and HospitalP3B (62)
Ketorolac Tromethamine
Advanced and Metastatic NSCLC
Tianjin Medical University Cancer Institute and HospitalP3B (62)
Irinotecan
Malignant Solid Tumor
Tianjin Medical University Cancer Institute and HospitalP2B (62)
Irinotecan
Pediatric Cancer
Tianjin Medical University Cancer Institute and HospitalP2B (62)
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Pancreatic Cancer
Tianjin Medical University Cancer Institute and HospitalP3B (61)
Benadryl
Advanced Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and HospitalP3B (60)
Irinotecan
Intrahepatic Cholangiocarcinoma (Icc)
Tianjin Medical University Cancer Institute and HospitalP3B (60)
Dc-Cik
First-line Treatment
Tianjin Medical University Cancer Institute and HospitalP2B (60)
dll3-car-nk cells
Extensive Stage Lung Small Cell Cancer
Tianjin Medical University Cancer Institute and HospitalP2B (60)
Iparomlimab
Iparomlimab and Tuvonralimab Injection
Tianjin Medical University Cancer Institute and HospitalP2B (60)
Showing 26 to 50 of 245 assets
PreviousPage 2 of 10Next